← ANALYST RATINGS · TIPRANKS
MiniMed Group, Inc. (MMED): analyst forecast and price target
Analyst consensus
Strong Buy12 Buy2 Hold0 Sell
Ratings of 14 analysts in the last 3 months12-month forecast
Based on 14 price targets given in the last 3 months, the average target is $26.15, the highest $30.00, the lowest $21.00. The average is +49.5% from the last price of $17.49.
Analyst ratings 17
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Equipment and ServicesxAI Grok-3 | TipRanks - xAI | $17.00 → $18.00+5.9% | Hold | +2.9% | Reiterated | 16.10.26on TipRanks 18:05 | — | |
| AI DeepSeek Medical - Equipment and ServicesDeepSeek R1-0528 | TipRanks - DeepSeek | $17.00 → $18.50+8.8% | Hold | +5.8% | Reiterated | 16.10.26on TipRanks 18:05 | — | |
| AI OpenAI Medical - Equipment and ServicesOpenAI 4o | TipRanks - OpenAI | $17.00 → $18.50+8.8% | Hold | +5.8% | Reiterated | 16.10.26on TipRanks 18:05 | — | |
| AI Anthropic Medical - Equipment and ServicesAnthropic Opus-4.6 | TipRanks - Anthropic | $16.50 → $18.00+9.1% | Hold | +2.9% | Reiterated | 16.10.26on TipRanks 18:05 | — | |
| AI Google Medical - Equipment and ServicesGemini 3.1Pro | TipRanks - Google | $17.00 → $18.50+8.8% | Hold | +5.8% | Reiterated | 16.10.26on TipRanks 18:05 | — | |
| AI PerPlexity Medical - Equipment and ServicesPerPlexity SonarPro | TipRanks - PerPlexity | $18.00 → $19.00+5.6% | Hold | +8.6% | Reiterated | 16.10.26on TipRanks 18:05 | — | |
| Issie Kirby★★★★★★★★★★#9228 · hits 27% · avg −2.0% | Rothschild & Co Redburn | $30.00 | Buy | +71.5% | Initiated | 13.10.26on TipRanks 05:16 | −2.1%next day −7.6% | ↗ |
| Michael Toomey★★★★★★★★★★#10023 · hits 29% · avg −6.8% | Jefferies | $22.00 | Hold | +25.8% | Initiated | 12.10.26on TipRanks 05:45 | −4.6%next day −2.1% | ↗ |
| Marie Thibault★★★★★★★★★★#12343 · hits 40% · avg −9.7% | BTIG | $28.00 | Buy | +60.1% | Reiterated | 09.10.26on TipRanks Oct 12 09:45 | −1.1%next day −4.6% · 5 days −9.3% | ↗ |
| Anthony Petrone★★★★★★★★★★#1225 · hits 54% · avg +8.5% | Mizuho Securities | $26.00 → $28.00+7.7% | Buy | +60.1% | Reiterated | 08.10.26on TipRanks 07:45 | +4.0%next day −1.1% · 5 days −8.8% | ↗ |
| Matt Miksic★★★★★★★★★★#2645 · hits 55% · avg +3.9% | Barclays | $22.00 | Hold | +25.8% | Initiated | 06.10.26on TipRanks 16:35 | −2.5%next day +4.0% · 5 days −11.1% | ↗ |
| Richard Newitter★★★★★★★★★★#1772 · hits 48% · avg +6.6% | Truist Financial | $29.00 | Buy | +65.8% | Initiated | 24.09.26on TipRanks 05:45 | −0.4%next day −2.8% · 5 days −3.7% | ↗ |
| Kallum Titchmarsh★★★★★★★★★★#2647 · hits 58% · avg +9.6% | Morgan Stanley | $21.00 | Buy | +20.1% | Assigned | 18.09.26on TipRanks 08:25 | −1.2%next day −4.6% · 5 days −9.6% | ↗ |
| Steven Lichtman★★★★★★★★★★#568 · hits 54% · avg +14.7% | William Blair | — | Buy | — | Reiterated | 14.09.26on TipRanks 11:45 | −1.9%next day +0.6% · 5 days −5.8% | ↗ |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $22.00 → $26.00+18.2% | Buy | +48.7% | Reiterated | 08.09.26on TipRanks Sep 9 06:20 | +0.7%next day −1.9% · 5 days −4.5% | ↗ |
| Pito Chickering★★★★★★★★★★#1500 · hits 61% · avg +9.8% | Deutsche Bank | $20.00 → $25.00+25.0% | Buy | +42.9% | Assigned | 02.09.26on TipRanks 09:25 | +5.5%next day −0.7% · 5 days −4.6% | ↗ |
| Daniel Markowitz CFA★★★★★★★★★★#1752 · hits 61% · avg +22.3% | Evercore ISI | $20.00 → $27.00+35.0% | Buy | +54.4% | Reiterated | 02.09.26on TipRanks 08:10 | +5.5%next day −0.7% · 5 days −4.6% | ↗ |
| Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% | UBS | $25.00 → $28.00+12.0% | Buy | +60.1% | Reiterated | 02.09.26on TipRanks 07:40 | +5.5%next day −0.7% · 5 days −4.6% | ↗ |
| Joanne Wuensch★★★★★★★★★★#3684 · hits 55% · avg +2.3% | Citi | $23.00 → $26.00+13.0% | Buy | +48.7% | Reiterated | 02.09.26on TipRanks 06:25 | +5.5%next day −0.7% · 5 days −4.6% | ↗ |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | $24.00 → $28.00+16.7% | Buy | +60.1% | Reiterated | 01.09.26on TipRanks Sep 2 05:15 | +11.3%next day +5.5% · 5 days +1.4% | ↗ |
| Matthew O'Brien★★★★★★★★★★#12031 · hits 41% · avg −4.5% | Piper Sandler | $16.00 | Hold | −8.5% | Reiterated | 04.06.26on TipRanks 06:55 | −1.8%next day +3.8% · 5 days +12.6% | ↗ |
| David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% | Goldman Sachs | $14.01 → $24.00+71.3% | Buy | +37.2% | Reiterated | 03.06.26on TipRanks Jun 4 07:50 | +16.6%next day −1.8% · 5 days +7.0% | ↗ |
| Bruce Jackson★★★★★★★★★★#12272 · hits 38% · avg −9.8% | Benchmark Co. | $20.00 | Buy | +14.4% | Reiterated | 03.06.26on TipRanks Jun 4 07:25 | +16.6%next day −1.8% · 5 days +7.0% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering MiniMed Group, Inc.
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $26.40 at a price of $19.47 (+35.6%); now: $26.15 at $17.49 (+49.5%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 12 | 8 | 2 | 1 |
| Buy | 7 | 8 | 10 | 12 | 19 | 18 |
| Hold | 1 | 1 | 1 | 1 | 0 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Best top-analyst consensus in the sector · General
About MiniMed Group, Inc.
- CEO: Que Thanh Dallara
- Employees: 8,000
- 18000 Devonshire Street, Northridge, CA, 91325, US
- www.minimed.com
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
Data from the stock’s TipRanks forecast page, read 18 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗